These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 8710380

  • 1. A novel p53 germline alteration identified in a late onset breast cancer kindred.
    Sun XF, Johannsson O, Håkansson S, Sellberg G, Nordenskjöld B, Olsson H, Borg A.
    Oncogene; 1996 Jul 18; 13(2):407-11. PubMed ID: 8710380
    [Abstract] [Full Text] [Related]

  • 2. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer.
    Lehman TA, Haffty BG, Carbone CJ, Bishop LR, Gumbs AA, Krishnan S, Shields PG, Modali R, Turner BC.
    Cancer Res; 2000 Feb 15; 60(4):1062-9. PubMed ID: 10706125
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Three germline mutations in the TP53 gene.
    Cornelis RS, van Vliet M, van de Vijver MJ, Vasen HF, Voute PA, Top B, Khan PM, Devilee P, Cornelisse CJ.
    Hum Mutat; 1997 Feb 15; 9(2):157-63. PubMed ID: 9067756
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene.
    Hamann U, Brauch H, Garvin AM, Bastert G, Scott RJ.
    Genes Chromosomes Cancer; 1997 Feb 15; 18(2):126-32. PubMed ID: 9115962
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
    Plummer SJ, Santibáñez-Koref M, Kurosaki T, Liao S, Noble B, Fain PR, Anton-Culver H, Casey G.
    Oncogene; 1994 Nov 15; 9(11):3273-80. PubMed ID: 7936651
    [Abstract] [Full Text] [Related]

  • 11. Novel germline mutation of the p53 tumor suppressor gene in a child with incidentally discovered adrenal cortical carcinoma.
    Grayson GH, Moore S, Schneider BG, Saldivar V, Hensel CH.
    Am J Pediatr Hematol Oncol; 1994 Nov 15; 16(4):341-7. PubMed ID: 7978053
    [Abstract] [Full Text] [Related]

  • 12. No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families.
    Warren W, Eeles RA, Ponder BA, Easton DF, Averill D, Ponder MA, Anderson K, Evans AM, DeMars R, Love R.
    Oncogene; 1992 May 15; 7(5):1043-6. PubMed ID: 1570151
    [Abstract] [Full Text] [Related]

  • 13. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
    Janatova M, Zikan M, Dundr P, Matous B, Pohlreich P.
    Hum Mutat; 2005 Mar 15; 25(3):319. PubMed ID: 15712267
    [Abstract] [Full Text] [Related]

  • 14. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
    Gayther SA, de Foy KA, Harrington P, Pharoah P, Dunsmuir WD, Edwards SM, Gillett C, Ardern-Jones A, Dearnaley DP, Easton DF, Ford D, Shearer RJ, Kirby RS, Dowe AL, Kelly J, Stratton MR, Ponder BA, Barnes D, Eeles RA.
    Cancer Res; 2000 Aug 15; 60(16):4513-8. PubMed ID: 10969800
    [Abstract] [Full Text] [Related]

  • 15. Inherited p53 gene mutations in breast cancer.
    Sidransky D, Tokino T, Helzlsouer K, Zehnbauer B, Rausch G, Shelton B, Prestigiacomo L, Vogelstein B, Davidson N.
    Cancer Res; 1992 May 15; 52(10):2984-6. PubMed ID: 1581912
    [Abstract] [Full Text] [Related]

  • 16. Germline mutations of the BRCA1 and BRCA2 genes in a breast and ovarian cancer patient.
    Randall TC, Bell KA, Rebane BA, Rubin SC, Boyd J.
    Gynecol Oncol; 1998 Sep 15; 70(3):432-4. PubMed ID: 9790802
    [Abstract] [Full Text] [Related]

  • 17. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
    Byrski T.
    Ann Acad Med Stetin; 2003 Sep 15; 49():27-43. PubMed ID: 15552838
    [Abstract] [Full Text] [Related]

  • 18. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL, Smith AM, Dávila MR, Sigurdson AJ, Giusti RM, Pineda MA, Doody MM, Tucker MA, Greene MH, Zhang J, Struewing JP.
    Hum Mutat; 2003 Aug 15; 22(2):121-8. PubMed ID: 12872252
    [Abstract] [Full Text] [Related]

  • 19. Germ-line splicing mutation of the p53 gene in a cancer-prone family.
    Warneford SG, Witton LJ, Townsend ML, Rowe PB, Reddel RR, Dalla-Pozza L, Symonds G.
    Cell Growth Differ; 1992 Nov 15; 3(11):839-46. PubMed ID: 1467311
    [Abstract] [Full Text] [Related]

  • 20. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM.
    Breast Cancer Res Treat; 2009 May 15; 115(1):51-5. PubMed ID: 18483852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.